• USA Home
  • B1680 - Bradyzide di(trifluoroacetate) salt hydrate

EMAIL THIS PAGE TO A FRIEND
B1680 Sigma

Bradyzide di(trifluoroacetate) salt hydrate

≥98%

Synonym: (S)-1-[4-(4-Benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl]-pyrrolidine-2-carboxylic acid [2-[(2-dimethylaminoethyl)methylamino]ethyl] amide

  • Empirical Formula (Hill Notation) C32H42N8O5S2 · 2C2HF3O2 · xH2O

  • Molecular Weight 910.90 (anhydrous basis)

  •  MDL number MFCD02684401

Purchase

Description

Biochem/physiol Actions

Potent, orally active, non-peptide B2 bradykinin receptor antagonist.

Packaging

25 mg in poly bottle

5 mg in glass bottle

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Price and Availability


Amplified Detection

Free Webinar

Amicon Ultra Centrifugal Filters
Safety & Documentation

Safety Information

RIDADR 
NONH for all modes of transport
WGK Germany 
3

Documents

Certificate of Analysis

Protocols & Articles
Peer-Reviewed Papers
15

References

Set your institution to view full text papers.
Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?